• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Neoprobe lands J&J as partner

Article

Gamma probe developer Neoprobe has signed an agreement with Johnson & Johnson’s Ethicon Endo-Surgery division for sales and marketing of Neoprobe 1500, a portable radioisotope detector recently released by Neoprobe. Ethicon Endo-Surgery of

Gamma probe developer Neoprobe has signed an agreement with Johnson & Johnson’s Ethicon Endo-Surgery division for sales and marketing of Neoprobe 1500, a portable radioisotope detector recently released by Neoprobe. Ethicon Endo-Surgery of Cincinnati, OH, will have rights to promote Neoprobe 1500 and its reusable probes for one year in the U.S., and the two companies are in discussions over extending the deal to cover Europe, Japan, and Australia. Neoprobe of Dublin, OH, previously had an agreement with U.S. Surgical, but that deal broke down last year.

Recent Videos
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.